Cardiology

Clinical trials beginning for possible preeclampsia treatment

For over 20 years, a team of researchers at Lund University has worked on developing a drug against preeclampsia—a serious disorder which annually affects around 9 million pregnant women worldwide and is one of the main ...

Cardiology

New approach uses magnetic beads to treat preeclampsia

Preliminary laboratory tests show that functionalized magnetic beads successfully reduced blood levels of a harmful molecule that is elevated during preeclampsia, according to new research in the American Heart Association's ...

Obstetrics & gynaecology

Preeclampsia treatment for mothers also benefits offspring

An estimated six to 15 million people in the U.S. are children born of a pregnancy complicated by preeclampsia. New research performed in rats reveals that treating preeclampsia with sildenafil citrate (Viagra) may help protect ...

Obstetrics & gynaecology

Pregnancy disorder subject of new Tulane study

An imaging technique used to detect some forms of cancer can also help detect preeclampsia in pregnancy before it becomes a life-threatening condition, a new Tulane study says.

Obstetrics & gynaecology

Improving pregnancy outcomes for black women

In June of 2018, tennis champion Serena Williams stunned the world by revealing the terrifying aftermath of giving birth to her daughter Olympia. With a history of blood clots, Williams was acutely aware of the post-delivery ...

Cardiology

Treatments for preeclampsia

Researchers at ETH Zurich have used trials with mice to shed light on signalling pathways that lead to thickened and less elastic blood vessels. They have developed a treatment approach for pregnant women with previously ...

Obstetrics & gynaecology

ACOG updates guidelines for gestational HTN, preeclampsia

(HealthDay)—The American College of Obstetricians & Gynecologists (ACOG) has updated its guidance on the management of gestational hypertension and preeclampsia as well as chronic hypertension in pregnant women; the two ...

page 1 from 12

Pre-eclampsia

Pre-eclampsia or preeclampsia is a medical condition in which hypertension arises in pregnancy (pregnancy-induced hypertension) in association with significant amounts of protein in the urine.

Pre-eclampsia refers to a set of symptoms rather than any causative factor, and there are many different causes for the condition. It appears likely that there are substances from the placenta that can cause endothelial dysfunction in the maternal blood vessels of susceptible women. While blood pressure elevation is the most visible sign of the disease, it involves generalized damage to the maternal endothelium, kidneys, and liver, with the release of vasoconstrictive factors being secondary to the original damage.

Pre-eclampsia may develop from 20 weeks gestation (it is considered early onset before 32 weeks, which is associated with increased morbidity). Its progress differs among patients; most cases are diagnosed pre-term. Pre-eclampsia may also occur up to six weeks post-partum. Apart from Caesarean section or induction of labor (and therefore delivery of the placenta), there is no known cure. It is the most common of the dangerous pregnancy complications; it may affect both the mother and the unborn child.

This text uses material from Wikipedia, licensed under CC BY-SA